guest ::
| Home > Publications database > Reassessing surgical resection in small cell lung cancer in the multimodal treatment era. |
| Home > Publications database > Reassessing surgical resection in small cell lung cancer in the multimodal treatment era. |
| Journal Article | DKFZ-2026-02294 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2026
Elsevier
Amsterdam [u.a.]
Abstract: Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases. Although up to 30% of patients present with locoregional disease, only a highly selected minority are considered candidates for multimodality treatment including surgical resection.In this single-center retrospective study, patients with SCLC who underwent surgical resection as part of a multimodality treatment approach between 2000 and 2023 were analyzed. Clinical, pathological, treatment-related variables, and follow-up data were collected. A control cohort of 115 patients treated with definitive chemoradiotherapy (CRT) during the same period was included. Propensity score matching (1:1) was performed based on age, sex, and UICC stage.A total of 115 patients (70 men, 45 women; median age 62.6 years) underwent surgical resection. Anatomical lung resection with systematic lymph node dissection was performed in 108 patients (93.9%), while 7 patients (6.1%) underwent wedge resection with lymphadenectomy. Platinum-based chemotherapy was administered in 92.2% of patients, and 31.1% received mediastinal radiotherapy. Median overall survival (OS) was significantly longer in the surgical cohort compared with the CRT cohort (57.3 vs. 21.7 months; p < 0.0001). In stage I-II disease, median OS was 88.5 months in the surgical group versus 26.1 months in the CRT group (p < 0.0001). On multivariable analysis, age, sex, tumor stage, and treatment modality were independently associated with OS.In this retrospective cohort, surgical resection as part of a multimodality treatment strategy was associated with favorable survival outcomes in highly selected patients with early-stage SCLC. Owing to the retrospective study design and the potential for residual selection bias, these findings should be considered hypothesis-generating and warrant prospective validation.
Keyword(s): Early stage ; Limited disease ; Multimodal ; SCLC ; Surgery ; Thoracic surgery
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz
; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
